Federal contractor · NORTH WALES, PA

TEVA PHARMACEUTICALS USA, INC.

TEVA PHARMACEUTICALS USA, INC. received $25.9M in federal contract obligations in FY2026, on 29 awards (−36% vs FY2025). Since FY2017: $243.8M. Its largest customer was Defense Logistics Agency ($25.9M).

Obligations · FY2026: $25.9M
New awards: 29
Sole-source: 100%
Single offer: 0.0%

UEI: NEN9A34LRHJ5

Other than small businessForeign-owned

Open in the contracts explorer Relationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

-11.2KFY2017
27MFY2020
40.5MFY2021
35.6MFY2022
36.1MFY2023
38.5MFY2024
40.2MFY2025
25.9MFY2026

Top buying agencies

Obligations in FY2026.

Defense Logistics Agency$25.9M100%
29 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

Health & medical$25.9M100%

Where the work was performed

Morris County, NJ$25.9M100%

Integrity signals

Shares of the year's obligations, next to the country's.

Low competition100%
US 39% · $25.9M
Sole-source awards100%
US 30% · $25.9M
Single-offer competitions0.0%
US 8.7% · $0
Urgency justifications0.0%
US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Agencies awarding it sole-source contracts

Defense Logistics Agency$25.9M
Department of Defense · 29 awards

Largest awards

8511984334!ADENOVIRUS TYPE 4 A$4M
Defense Logistics Agency· Morris County, NJ· Health & medical· Mar 18, 2026 – Mar 18, 2026· SPE2DP26F3586
8511856699!ADENOVIRUS TYPE 4 A$4M
Defense Logistics Agency· Morris County, NJ· Health & medical· Jan 13, 2026 – Jan 13, 2026· SPE2DP26F1649
8511918533!ADENOVIRUS TYPE 4 A$4M
Defense Logistics Agency· Morris County, NJ· Health & medical· Feb 17, 2026 – Feb 17, 2026· SPE2DP26F2814
8511784063!ADENOVIRUS TYPE 4 A$2M
Defense Logistics Agency· Morris County, NJ· Health & medical· Dec 1, 2025 – Dec 1, 2025· SPE2DP26F0979
8511784064!ADENOVIRUS TYPE 4 A$1.3M
Defense Logistics Agency· Morris County, NJ· Health & medical· Dec 1, 2025 – Dec 1, 2025· SPE2DP26F0980
8512097239!ADENOVIRUS TYPE 4 A$1M
Defense Logistics Agency· Morris County, NJ· Health & medical· May 11, 2026 – May 11, 2026· SPE2DP26F5466
8512041924!ADENOVIRUS TYPE 4 A$1M
Defense Logistics Agency· Morris County, NJ· Health & medical· Apr 15, 2026 – Apr 15, 2026· SPE2DP26F4633
8512097278!ADENOVIRUS TYPE 4 A$687.1K
Defense Logistics Agency· Morris County, NJ· Health & medical· May 11, 2026 – May 11, 2026· SPE2DP26F5469

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 1 market (agency × industry), FY2024–FY2026.

VALNEVA USA, INC.$79.6M+18% in FY2026
BETHESDA, MD · 37% of this company's obligations are in markets they both serveDefense Logistics Agency · Pharmaceutical and medicine manufacturing
SANOFI VACCINES US INC.$163.4M−56% in FY2026
SWIFTWATER, PA · 2 entities · 28% of this company's obligations are in markets they both serveDefense Logistics Agency · Pharmaceutical and medicine manufacturing
ANALOGIC CORP$322.8M+119% in FY2026
PEABODY, MA · 2 entities · 44% of this company's obligations are in markets they both serveDefense Logistics Agency · Pharmaceutical and medicine manufacturing

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.

Lobbying and PAC activity

Organizations in House lobbying disclosures and FEC records whose names an AI judgment matched to this company. Those records carry no identifier shared with contracts, so every match is by name.

Matched organizations

TEVA PHARMACEUTICALS USA, INC.AI match · 100%

Lobbying · 2025: $2.5M; 15 reports
Lobbying · 2023–2026: $8.4M; $8.4M in its own reports
PAC giving · 2026: $29K; 1 PAC

Lobbying by year

2023$2.1M
11 reports
2024$2.3M
14 reports
2025$2.5M
15 reports
2026$1.5M
11 reports

Top issues

Health issues40 reports
Medicare and Medicaid14 reports
Pharmacy10 reports
Copyright, patent and trademark7 reports
Miscellaneous tariff bills6 reports
Trade (domestic and foreign)6 reports
Manufacturing2 reports

Who was contacted

U.S. SENATE40 reports
U.S. HOUSE OF REPRESENTATIVES37 reports
Health & Human Services - Dept of (HHS)18 reports
Centers For Medicare and Medicaid Services (CMS)14 reports
Executive Office of the President (EOP)14 reports
Food & Drug Administration (FDA)14 reports
Commerce - Dept of (DOC)10 reports
Homeland Security - Dept of (DHS)10 reports
U.S. Trade Representative (USTR)6 reports

Houses of Congress and federal agencies the reports list as contacted (a report names every one for all its issues).

Lobbying firms hired

Capitol Hill Consulting Group$840K
14 reports
Mr. David Friedman$550K
3 reports
Faegre Drinker Biddle & Reath LLP$520K
9 reports
Talley Strategies LLC$160K
5 reports
COLAS & ASSOCIATES, LLC$60K
3 reports
Polsinelli PC$30K
2 reports
The Smith-Free Group, LLC$0
1 reports

Registrants who are individuals are counted, not named.

PAC giving to candidates by party, 2026 cycle

Democratic$23K79%
Republican$6,00021%

PACs sponsored

TEVA PHARMACEUTICALS USA INC. POLITICAL ACTION COMMITTEE (TEVA PAC)$75.5K raised this cycle

PACs these organizations sponsor (connected organizations in FEC records). A PAC gives employees' and members' voluntary contributions, not the company's own money.

Lobbying amounts are the filers' own good-faith estimates on quarterly LD-2 reports (the law asks for amounts rounded to $10,000; under $5,000 need not be itemized), latest amendment only. When an organization files its own report, it replaces what outside firms report for it that quarter. Matches are by name. Lobbying and political giving are legal and public: they show engagement with government, not influence over any award. Correlation is not influence: these organizations' lobbying and their contracts are shown side by side, and nothing here implies either affected the other.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2023–2026.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026 · 2026, 2024, 2022.

Matches: Analisa AI name judgments (entity-match@1), updated Sep 30, 2026.

Congress: members and bills

Through the organizations matched to this company: members of Congress whose campaigns received contributions from their PACs, and the bills their lobbying reports named. Shown beside the company's contracts as a comparison, not a cause.

Members whose campaigns received from its PACs, 2026 cycle

Ben Ray Luján$5,000
D-NM · Senate · 1 PAC
Robert Menendez$5,000
D-NJ-8 · House · 1 PAC
Jerrold Nadler$5,000
D-NY-12 · House · 1 PAC
Tom Cotton$3,500
R-AR · Senate · 1 PAC
H. Morgan Griffith$3,500
R-VA-9 · House · 1 PAC
Chrissy Houlahan$3,500
D-PA-6 · House · 1 PAC
John Joyce$2,500
R-PA-13 · House · 1 PAC
Jake Auchincloss$1,500
D-MA-4 · House · 1 PAC
Diana DeGette$1,500
D-CO-1 · House · 1 PAC
Doris O. Matsui$1,500
D-CA-7 · House · 1 PAC

$29K of the $29K its PACs gave to federal candidates went to 11 members of Congress.

Members whose campaigns received from its PACs, 2024 cycle

John R. Curtis$10K
R-UT · Senate · 1 PAC
Brett Guthrie$10K
R-KY-2 · House · 1 PAC
Bill Cassidy$7,500
R-LA · Senate · 1 PAC
Robert P. Casey, Jr.$5,000
D-PA · Senate · 1 PAC
Chrissy Houlahan$3,500
D-PA-6 · House · 1 PAC

Direct and in-kind contributions the members' campaigns received (FEC), net of refunds. Party and seat are the member's current or latest.

Bills named in its lobbying reports

H.R. 1613 · Drug Price Transparency in Medicaid Act of 20236 reports
118th Congress · Introduced · 2023–2024
H.R. 5378 · Lower Costs, More Transparency Act6 reports
118th Congress · Passed one chamber · 2023–2024
S. 113 · Prescription Pricing for the People Act of 20236 reports
118th Congress · Reported by committee · 2023–2024
S. 127 · Pharmacy Benefit Manager Transparency Act of 20236 reports
118th Congress · Reported by committee · 2023–2024
S. 142 · Preserve Access to Affordable Generics and Biosimilars Act6 reports

Amounts, members and bills are as recorded, shown side by side. They say nothing about why a contribution was made, how a member voted or what a report sought. A bill number written in a report is read as the measure of the Congress its context points to (a law's number, the Congress written next to it, the title), else of the Congress then sitting.

Source: Committees, candidates and committee contributions to candidates (Federal Election Commission), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives), data current to Oct 9, 2026, loaded Oct 9, 2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.